Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are male or female and are 18 years of age or older
- You have been newly diagnosed with a lung condition called PID (pulmonary interstitial disease) within the last six months, confirmed by a lung specialist
- You have had certain tests done within the last six months, including a chest CT scan, breathing tests, and some blood tests to check your immune system (confirm with trial site for full details)
- You speak French and have no difficulties understanding information given to you
- You are covered by a social security or health insurance system
- You are willing and able to give your written agreement to take part in the trial before any study-related tests begin
Who may not be able to join:
- You have previously had a test called capillaroscopy (a test that looks at tiny blood vessels, usually near the fingernails) for any reason
- You have been diagnosed with, or are strongly suspected of having, a connective tissue disease (a condition affecting the body's connective tissues, such as lupus or rheumatoid arthritis) based on your initial medical assessments
- You have already started taking certain medications for your lung condition, such as steroid tablets, drugs that suppress the immune system, or anti-fibrotic (anti-scarring) drugs
- You are currently pregnant or breastfeeding
- You belong to a group of people who are protected under specific French legal rules, such as people whose freedom is restricted by a legal decision, minors, people under legal guardianship, or people who are unable to give their own consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marie-Elise TRUCHETET, MD, PhD, University Hospital, Bordeaux
Phone: 05.56.79.55.56
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of capillaroscopy abnormalities according to the classification proposed by the EULAR Study Group on Microcirculation in Rheumatic Diseases
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.